Work

A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia

Year: 2007

Type: article

Study design: Clinical Trial

Source: Leukemia

DOI: 10.1038/sj.leu.2404816

Authors: R A Mesa, J K Camoriano, S M Geyer, W Wu, S H Kaufmann, C E Rivera, C Erlichman, J Wright, A Pardanani, T Lasho, C Finke, C Y Li, A Tefferi

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), National Institutes of Health, National Cancer Institute

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G3873038914, Early Therapeutics Development with Phase II Emphasis, G844520391, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W2091165956

FWCI: 3.807

Cites: 33

Cited by: 38

Related to: 10